Picture of Divi's Laboratories logo

DIVISLAB — Divi's Laboratories News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's drugmakers drop on uncertainty over US tariff threats

** India's pharmaceutical companies  .NIPHARM  drop 1.7%,
with 19 of the 20 constituents trading in the red    
    ** The index has lost about 7.6% over two weeks, pressured
by the uncertainty over U.S. tariffs following President Donald
Trump's plans to levy at least 25% tariff on pharmaceutical
imports
    ** The United States is India's biggest pharmaceuticals
market
    ** Domestic drugmakers are hoping that discussions between
the U.S. and India will help them steer clear of Trump's tariff
threat, a trade association says
    ** Indian pharma companies to remain volatile and could see
further pressure due to U.S. tariff, says Citi Research
    ** Citi prefers drugmakers such as Divi's Laboratories
 DIVI.NS , Sun Pharma  SUN.NS  and Torrent Pharma  TORP.NS  
with lower exposure to U.S. generics
    ** The pharma index is down 2% for the week, against the
Nifty's 0.6% drop, making it one of the worst-performing sectors

 (Reporting by Bharath Rajeswaran in Bengaluru)
 ((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))

Recent news on Divi's Laboratories

See all news